Cargando…
Acute seizures and status epilepticus in immune effector cell associated neurotoxicity syndrome (ICANS)
Autores principales: | Saw, Jacqui-Lyn, Sidiqi, M. Hasib, Ruff, Michael, Hocker, Sara, Alkhateeb, Hassan, Ansell, Stephen M., Bennani, N. Nora, Dingli, David, Hayman, Suzanne R., Johnston, Patrick B., Kapoor, Prashant, Kenderian, Saad J., Kourelis, Taxiarchis V., Kumar, Shaji K., Paludo, Jonas, Shah, Mithun V., Siddiqui, Mustaqeem A., Warsame, Rahma, Rosenthal, Allison, Grill, Marie, Castro, Januario E., Siegel, Jason, Abdel Rahman, Zaid H., Kharfan-Dabaja, Mohamed A., So, Elson, Lin, Yi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9007939/ https://www.ncbi.nlm.nih.gov/pubmed/35418113 http://dx.doi.org/10.1038/s41408-022-00657-x |
Ejemplares similares
-
S263: CYTOPENIAS, AGE AND CAR-HEMATOTOX SCORE PREDICT THE DEVELOPMENT OF POST CAR T-CELL THERAPY-RELATED MYELOID NEOPLASMS
por: Gurney, Mark, et al.
Publicado: (2023) -
P-207: Impact of the time interval between end of induction and autologous hematopoietic transplantation in newly diagnosed patients with multiple myeloma
por: Charalampous, Charalampos, et al.
Publicado: (2022) -
Impact of the time interval between end of induction and autologous hematopoietic transplantation in newly diagnosed patients with multiple myeloma
por: Charalampous, Charalampos, et al.
Publicado: (2022) -
Response to COVID-19 Vaccination Post-CAR T Therapy in Patients with Non-Hodgkin Lymphoma and Multiple Myeloma
por: Wiedmeier-Nutor, Julia Erin, et al.
Publicado: (2022) -
Response to COVID-19 Vaccination Post-CAR T Therapy in Patients with Non-Hodgkin Lymphoma and Multiple Myeloma
por: Wiedmeier, Julia E., et al.
Publicado: (2021)